Management of Type 2 Diabetes With Insulin Glargine-100 in Iraq in a Real-Life Observation.

Insulin-naïve patients showed a higher response to Glar-100 (a reduction of 31.3% at month 3 and 37.4% at month 6) than previously insulinized patients (a reduction of 25.2% at month 3 and 32.7% at month 6), but this difference did not reach statistical significance (P = 0.420, using the Mann-Whitney U test).

also in 111,027 other papers

Although the average doses received by insulin-naïve patients were much lower than those received by patients with prior insulin exposure, only seven patients were following a basal-bolus regimen at baseline, and the difference failed to reach statistical significance.

also in 6,035 other papers